BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koike K. The oncogenic role of hepatitis C virus. Recent Results Cancer Res. 2014;193:97-111. [PMID: 24008295 DOI: 10.1007/978-3-642-38965-8_6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 El-Bendary M, Neamatallah M, Elalfy H, Besheer T, El-Setouhy M, Youssef MM, Zein M, Elhammady D, Hegazy A, Esmat G. Association of genetic polymorphisms of chemokines and their receptors with clearance or persistence of hepatitis C virus infection. Br J Biomed Sci. 2019;76:11-16. [PMID: 30175654 DOI: 10.1080/09674845.2018.1518299] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
2 Wijetunga NA, Pascual M, Tozour J, Delahaye F, Alani M, Adeyeye M, Wolkoff AW, Verma A, Greally JM. A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets. Oncogene. 2017;36:2030-2044. [PMID: 27721404 DOI: 10.1038/onc.2016.340] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
3 Igloi Z, Kazlauskas A, Saksela K, Macdonald A, Mankouri J, Harris M. Hepatitis C virus NS5A protein blocks epidermal growth factor receptor degradation via a proline motif- dependent interaction. J Gen Virol 2015;96:2133-44. [PMID: 25872741 DOI: 10.1099/vir.0.000145] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
4 Zhou Y, Chen N, Liu X, Lin S, Luo W, Liu M. Kushenin induces the apoptosis of HCV-infected cells by blocking the PI3K-Akt-mTOR pathway via inhibiting NS5A. Exp Cell Res. 2016;345:108-114. [PMID: 27237092 DOI: 10.1016/j.yexcr.2016.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
5 Morgan TR, Osann K, Bottiglieri T, Pimstone N, Hoefs JC, Hu KQ, Hassanein T, Boyer TD, Kong L, Chen WP, Richmond E, Gonzalez R, Rodriguez LM, Meyskens FL. A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP. Cancer Prev Res (Phila) 2015;8:864-72. [PMID: 26130251 DOI: 10.1158/1940-6207.CAPR-15-0029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
6 Ampuero J, Romero-Gómez M. Assessing cardiovascular risk in hepatitis C: An unmet need. World J Hepatol. 2015;7:2214-2219. [PMID: 26380047 DOI: 10.4254/wjh.v7.i19.2214] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
7 Ampuero J, Romero-Gómez M, Reddy KR. Review article: HCV genotype 3 – the new treatment challenge. Aliment Pharmacol Ther. 2014;39:686-698. [PMID: 24612116 DOI: 10.1111/apt.12646] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 11.6] [Reference Citation Analysis]
8 Niedźwiedzka-Rystwej P, Grywalska E, Hrynkiewicz R, Wołącewicz M, Becht R, Roliński J. The Double-Edged Sword Role of Viruses in Gastric Cancer.Cancers (Basel). 2020;12. [PMID: 32599870 DOI: 10.3390/cancers12061680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Shearn CT, Petersen DR. Understanding the Tumor Suppressor PTEN in Chronic Alcoholism and Hepatocellular Carcinoma. In: Vasiliou V, Zakhari S, Seitz HK, Hoek JB, editors. Biological Basis of Alcohol-Induced Cancer. Cham: Springer International Publishing; 2015. pp. 173-84. [DOI: 10.1007/978-3-319-09614-8_10] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
10 Khachatoorian R, French SW. Chaperones in hepatitis C virus infection. World J Hepatol 2016;8:9-35. [PMID: 26783419 DOI: 10.4254/wjh.v8.i1.9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]